Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping

Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Y. Neufeld, F. Mawassi, A. Levy, T. A. Treves, A. D. Korczyn
Format: Article
Language:English
Published: Wiley 1993-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.3233/BEN-1993-6105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560788128137216
author M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
author_facet M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
author_sort M. Y. Neufeld
collection DOAJ
description Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.
format Article
id doaj-art-12a7f82dae04447c9e09e29d9bf735d6
institution Kabale University
issn 0953-4180
1875-8584
language English
publishDate 1993-01-01
publisher Wiley
record_format Article
series Behavioural Neurology
spelling doaj-art-12a7f82dae04447c9e09e29d9bf735d62025-02-03T01:26:42ZengWileyBehavioural Neurology0953-41801875-85841993-01-0161333510.3233/BEN-1993-6105Transdermal Physostigmine—Absence of Effect on Topographic Brain MappingM. Y. Neufeld0F. Mawassi1A. Levy2T. A. Treves3A. D. Korczyn4Department of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelIsrael Institute for Biological Research, Ness Ziona, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelNine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.http://dx.doi.org/10.3233/BEN-1993-6105
spellingShingle M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
Behavioural Neurology
title Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_full Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_fullStr Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_full_unstemmed Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_short Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_sort transdermal physostigmine absence of effect on topographic brain mapping
url http://dx.doi.org/10.3233/BEN-1993-6105
work_keys_str_mv AT myneufeld transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT fmawassi transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT alevy transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT tatreves transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT adkorczyn transdermalphysostigmineabsenceofeffectontopographicbrainmapping